Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions

Purpose Intratumoral metabolic heterogeneity may increase the likelihood of treatment failure due to the presence of a subset of resistant tumor cells. Using a head and neck squamous cell carcinoma (HNSCC) xenograft model and a real-time fluorescence imaging approach, we tested the hypothesis that tumors are metabolically heterogeneous, and that tumor hypoxia alters patterns of glucose uptake within the tumor. Experimental Design Cal33 cells were grown as xenograft tumors (n = 16) in nude mice after identification of this cell line's metabolic response to hypoxia. Tumor uptake of fluorescent markers identifying hypoxia, glucose import, or vascularity was imaged simultaneously using fluorescent molecular tomography. The variability of intratumoral 2-deoxyglucose (IR800-2-DG) concentration was used to assess tumor metabolic heterogeneity, which was further investigated using immunohistochemistry for expression of key metabolic enzymes. HNSCC tumors in patients were assessed for intratumoral variability of 18F-fluorodeoxyglucose (18F-FDG) uptake in clinical PET scans. Results IR800-2-DG uptake in hypoxic regions of Cal33 tumors was 2.04 times higher compared to the whole tumor (p = 0.0001). IR800-2-DG uptake in tumors containing hypoxic regions was more heterogeneous as compared to tumors lacking a hypoxic signal. Immunohistochemistry staining for HIF-1α, carbonic anhydrase 9, and ATP synthase subunit 5β confirmed xenograft metabolic heterogeneity. We detected heterogeneous 18F-FDG uptake within patient HNSCC tumors, and the degree of heterogeneity varied amongst tumors. Conclusion Hypoxia is associated with increased intratumoral metabolic heterogeneity. 18F-FDG PET scans may be used to stratify patients according to the metabolic heterogeneity within their tumors, which could be an indicator of prognosis.

[1]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[2]  P. Grigsby,et al.  Intratumoral Metabolic Heterogeneity of Cervical Cancer , 2008, Clinical Cancer Research.

[3]  D. Brizel,et al.  Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  M. Molls,et al.  Monitoring PAI-1 and VEGF levels in 6 human squamous cell carcinoma xenografts during fractionated irradiation. , 2012, International journal of radiation oncology, biology, physics.

[5]  Dimitris Visvikis,et al.  Impact of Tumor Size and Tracer Uptake Heterogeneity in 18F-FDG PET and CT Non–Small Cell Lung Cancer Tumor Delineation , 2011, The Journal of Nuclear Medicine.

[6]  J. Bussink,et al.  Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Ronald Boellaard,et al.  Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  Kornelia Polyak,et al.  Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.

[9]  Simon C Watkins,et al.  Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress , 2012, Journal of Cell Science.

[10]  T. Reichert,et al.  Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue , 2011, Journal of Cancer Research and Clinical Oncology.

[11]  B. C. Penney,et al.  Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. , 2013, Academic radiology.

[12]  A. Kung,et al.  Incongruity of Imaging Using Fluorescent 2-DG Conjugates Compared to 18F-FDG in Preclinical Cancer Models , 2012, Molecular Imaging and Biology.

[13]  T. Odajima,et al.  Establishment and Characterization of a Human Cell Line Derived from a Squamous Cell Carcinoma of the Tongue , 1988 .

[14]  J. Bussink,et al.  Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4 , 2011, BMC Cancer.

[15]  G. Leroux-Roels,et al.  Laboratory Assessment of Five Glucose Meters Designed for Self-Monitoring of Blood Glucose Concentration , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[16]  F. Demard,et al.  Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. , 1988, European journal of cancer & clinical oncology.

[17]  J. Myers,et al.  Xenograft models of head and neck cancers , 2009, Head & neck oncology.

[18]  Ivo Que,et al.  Dual-Wavelength Imaging of Tumor Progression by Activatable and Targeting Near-Infrared Fluorescent Probes in a Bioluminescent Breast Cancer Model , 2012, PloS one.

[19]  I. Robey,et al.  Investigating Mechanisms of Alkalinization for Reducing Primary Breast Tumor Invasion , 2013, BioMed research international.

[20]  M. Al‐Rubeai,et al.  Cellular and transcriptomic analysis of NS0 cell response during exposure to hypoxia. , 2008, Journal of biotechnology.

[21]  N. Denko,et al.  Hypoxia, HIF1 and glucose metabolism in the solid tumour , 2008, Nature Reviews Cancer.

[22]  Valentino Bettinardi,et al.  Performance evaluation of the new whole-body PET/CT scanner: Discovery ST , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  G. Kroemer,et al.  High-mobility group box 1 is essential for mitochondrial quality control. , 2011, Cell metabolism.

[24]  B. Van Houten,et al.  Metabolic symbiosis in cancer: Refocusing the Warburg lens , 2013, Molecular carcinogenesis.

[25]  James B. Mitchell,et al.  Imaging cycling tumor hypoxia. , 2010, Cancer research.

[26]  Meng Yang,et al.  The role of the intravascular microenvironment in spontaneous metastasis development , 2010, International journal of cancer.

[27]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[28]  H. Taubert,et al.  Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck Cancer , 2008, Strahlentherapie und Onkologie.

[29]  P. Vaupel,et al.  Carbonic Anhydrase IX Expression and Tumor Oxygenation Status Do Not Correlate at the Microregional Level in Locally Advanced Cancers of the Uterine Cervix , 2005, Clinical Cancer Research.

[30]  Ralph Weissleder,et al.  Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct , 2007, Circulation research.

[31]  David L. Schwartz,et al.  Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.

[32]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[33]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[34]  D. Bigner,et al.  Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation , 2009, Oncogene.

[35]  B. Van Houten,et al.  Alterations in bioenergetics due to changes in mitochondrial DNA copy number. , 2010, Methods.

[36]  J. Bussink,et al.  TUMOR MICROENVIRONMENT IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS : PREDICTIVE VALUE AND CLINICAL RELEVANCE OF HYPOXIC MARKERS , 2007 .

[37]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[38]  C. Drouet.  Apatite Formation: Why It May Not Work as Planned, and How to Conclusively Identify Apatite Compounds , 2013, BioMed research international.

[39]  Ralph P. Mason,et al.  Dynamic Near-Infrared Optical Imaging of 2-Deoxyglucose Uptake by Intracranial Glioma of Athymic Mice , 2009, PloS one.

[40]  F. O’Sullivan,et al.  Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.

[41]  G. Mills,et al.  Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.

[42]  Mark W. Dewhirst,et al.  Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response , 2008, Nature Reviews Cancer.

[43]  Daniela Thorwarth,et al.  Combined uptake of [18F]FDG and [18F]FMISO correlates with radiation therapy outcome in head-and-neck cancer patients. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  Eva Sevick-Muraca,et al.  Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. , 2009, Analytical Biochemistry.

[45]  B. C. Penney,et al.  Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[46]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.